Newcastle University

Research Interests

Dr Turkington has carried out research into the efficacy and effectiveness of cognitive behavioural therapy (CBT) in the treatment of schizophrenia. He has carried out randomised controlled trials of CBT versus befriending and of CBT versus treatment as usual in community settings. He has also conducted short and medium term follow ups. He has written three books on the use of CBT in schizophrenia, one of these being a treatment manual. Currently he has submitted grant applications for CBT to treat impaired adherence in schizophrenia in a combined study with the State University of New York. He has also submitted a grant application for the use of CBT in first episode schizophrenia linking with the University of Glasgow. He has carried out a randomised trial of Fluvoxamine in the treatment of Prostatodynia and is currently researching the use of Modafinil in chronic fatigue syndrome.

Current Work

Professor of Psychosocial Psychiatry and Consultant Liaison Psychiatrist.

Esteem Indicators

Wellcome trust grant holder.

Undergraduate Teaching

National and international teaching on CBT of psychotic disorders including symposia, seminars and workshops.

• Samarasekera N, Kingdon D, Siddle R, O'Carroll M, Scott JL, Sensky T, Barnes TRE, Turkington D. Befriending patients with medication-resistant schizophrenia: Can psychotic symptoms predict treatment response?. Psychology and Psychotherapy: Theory, Research and Practice 2007, 80, 97-106.
• Turkington D, Hedwat D, Rider I, Young AH. Recovery from chronic fatigue syndrome with modafinil. Human Psychopharmacology: Clinical and Experimental 2004,19 1 63-64.
• Hansen L, Turkington D, Kingdon D, Smith P. Brief rating instrument for assessment of negative symptoms: Derived from the Comprehensive Psychopathological Rating Scale. International Journal of Psychiatry in Clinical Practice 2003, 7(2), 113-116.
• Morrison AP, Turkington D, Wardle M, Spencer H, Barratt S, Dudley R, Brabban A, Hutton P. A preliminary exploration of predictors of outcome and cognitive mechanisms of change in cognitive behaviour therapy for psychosis in people not taking antipsychotic medication. Behaviour Research and Therapy 2012, 50(2), 163-167.
• Kinoshita Y, Kingdon D, Kinoshita K, Sarafudheen S, Umadi D, Dayson D, Hansen L, Rathod S, Ibbotson RB, Turkington D, Furukawa TA. A semi-structured clinical interview for psychosis sub-groups (SCIPS): development and psychometric properties. Social Psychiatry and Psychiatric Epidemiology 2012, 47(4), 563-580.
• Kingdon DG, Solomka B, McAllister-Williams H, Turkington D, Gregoire A, Elnazer H, Thagadur M, Hansen L, Rathod S, Gleeson S, Zoha M, Singh P, Naeem F. Care clusters and mental health Payment by Results. British Journal of Psychiatry 2012, 200(2), 162-162.
• Turkington D, Morrison AP. Cognitive Therapy for Negative Symptoms of Schizophrenia. Archives of General Psychiatry 2012, 69(2), 119-120.
• Turkington D, Kingdon D, Chadwick P. Cognitive-behavioural therapy for schizophrenia: filling the therapeutic vacuum. British Journal of Psychiatry 2003, 183(2), 98-99.
• Turkington D, McKenna P. Is cognitive-behavioural therapy a worthwhile treatment for psychosis?. British Journal of Psychiatry 2003, 182, 477-479.
• Turkington D. Psychologic mechanisms of psychosis. Advanced Studies in Medicine 2003, 3(8C), S773-S775.
• Kuipers E, Garety P, Dunn G, Bebbington P, Fowler D, Freeman D, Turkington D. CBT for psychosis. British Journal of Psychiatry 2002, 181, 534.
• Turkington D. CBT for psychosis - Reply. British Journal of Psychiatry 2002, 181(6), 534.
• Turkington D. Cognitive-behavioural therapy for schizophrenia. British Journal of Psychiatry 2002, 181(5), 439-440.
• Turkington D, Kingdon DG, Turner T, Insight Schizophrenia Res Grp. Does brief cognitive behavioural therapy have a durable effect?. In: Schizophrenia Research: XIth Biennial Winter Workshop on Schizophrenia. 2002, Davos, Switzerland: Elsevier BV.
• Turkington D, Kingdon DG, Turner T, Insight Schizophrenia Res Grp. Effectiveness of a brief cognitive behavioural intervention in the treatment of schizophrenia. In: Schizophrenia Research: XIth Biennial Winter Workshop on Schizophrenia. 2002, Davos, Switzerland: Elsevier BV.
• Moorhead S, Turkington D. Role of emotional capacity in consent should be clarified. British Medical Journal 2002, 325(7371), 1039.
• Turkington D, Kingdon DG. Cognitive-behavioural techniques in practice - Authors' reply. British Journal of Psychiatry 2001, 178(1), 180-180.
• McGovern J, Turkington D. 'Seeing the wood from the trees': A continuum model of psychopathology advocating cognitive behaviour therapy for schizophrenia. Clinical Psychology & Psychotherapy 2001, 8(3), 149-175.
• Moorhead S, Turkington D. The CBT of delusional disorder: The relationship between schema vulnerability and psychotic content. British Journal of Medical Psychology 2001, 74(4), 419-430.
• Sensky T, Turkington D, Kingdon D, Scott J, Siddle R, O'Carroll M, Barnes TRE. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry 2000, 57(2), 165-172.
• Turkington D, Kingdom D. Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry 2000, 177, 101-106.